Zealand Pharma A/S
CSE:ZEAL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zealand Pharma A/S
CSE:ZEAL
|
DK |
Wall St Price Targets
ZEAL Price Targets Summary
Zealand Pharma A/S
According to Wall Street analysts, the average 1-year price target for ZEAL is 556.31 DKK with a low forecast of 303 DKK and a high forecast of 950.25 DKK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZEAL's stock price target?
Price Target
556.31
DKK
According to Wall Street analysts, the average 1-year price target for ZEAL is 556.31 DKK with a low forecast of 303 DKK and a high forecast of 950.25 DKK.
What is the Revenue forecast for Zealand Pharma A/S?
Projected CAGR
-8%
Over the last 14 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is -8%.
What is the Operating Income forecast for Zealand Pharma A/S?
Projected CAGR
-20%
Over the last 14 years, the compound annual growth rate for Operating Income has been 61%. The projected CAGR for the next 8 years is -20%.
What is the Net Income forecast for Zealand Pharma A/S?
Projected CAGR
-29%
Over the last 14 years, the compound annual growth rate for Net Income has been 55%. The projected CAGR for the next 8 years is -29%.
